跳至主要内容
临床试验/NCT05329077
NCT05329077已完成不适用

A Study to Assess the Safety and Efficacy of Pulsenmore ES Home Ultrasound Device in Pregnant Women

PulseNmore7 个研究点 分布在 1 个国家目标入组 188 人开始时间: 2022年4月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
PulseNmore
入组人数
188
试验地点
7
主要终点
Comparison of device derived presence or absence of fetal cardiac activity to ground truth

研究概览

简要总结

This is a multicenter, prospective, investigational device study designed to evaluate:

The safety, feasibility, and accuracy of the device, when used by pregnant individuals

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Singleton gestation.
  • Gestational age >14 weeks with a prior scan demonstrating fetal viability and confirming dates.
  • English or Spanish speaking.
  • Ability to understand and sign the informed consent (available in English and Spanish).
  • Ability to read and understand instructions that are required for equipment use (instructions available in both languages).

排除标准

  • Multiple gestations.
  • Known fetal and genetic anomalies.
  • Subjects with skin problems in the abdominal area (such as wounds, cuts in the skin, and skin rash).
  • Subjects allergic to the ultrasound probe materials.
  • Non-English/ non-Spanish speaking.
  • Unable to provide consent.

结局指标

主要结局

Comparison of device derived presence or absence of fetal cardiac activity to ground truth

时间窗: Test to be conducted during week 14-38 of pregnancy

The presence or absence of device derived fetal cardiac activity would be matched with the presence or absence of fetal cardiac activity derived by the ground truth (in-clinic ultrasound scan)

Comparison of device derived amniotic fluid level status, normal or abnormal, to ground truth

时间窗: Test to be conducted during week 14-38 of pregnancy

Comparison of device derived amniotic fluid level status, normal or abnormal, (measured by maximal vertical pocket in cm) would be matched with amniotic fluid level status derived from the ground truth (in-clinic ultrasound scan)

次要结局

  • Ability to detect fetal movement from device derived input will be compared to the ground truth(Test to be conducted during week 14-38 of pregnancy)
  • Ability to assess placental location from device derived input will be compared to the ground truth(Test to be conducted during week 14-38 of pregnancy)
  • Ability to detect fetal breathing from device derived input will be compared to the ground truth(Test to be conducted during week >27-38 of pregnancy)
  • Ability to assess fetal presentation from device derived input will be compared to the ground truth(Test to be conducted during week 14-38 of pregnancy)

研究者

发起方
PulseNmore
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验